Table 3.
<10 mIU/mL | ||
---|---|---|
Primary response | 1 year post-vaccination | 2 years post-vaccination |
10-100 | 17/38 (44.7%)* | 9/10 (90.0%)* |
100< | 1/209 (0.5%) | 8/81 (9.9%) |
*p<0.05, anti-HBs titer of 10-100 mIU/mL vs. anti-HBs titer >100 mIU/mL
<10 mIU/mL | ||
---|---|---|
Primary response | 1 year post-vaccination | 2 years post-vaccination |
10-100 | 17/38 (44.7%)* | 9/10 (90.0%)* |
100< | 1/209 (0.5%) | 8/81 (9.9%) |
*p<0.05, anti-HBs titer of 10-100 mIU/mL vs. anti-HBs titer >100 mIU/mL